UTMD icon

Utah Medical Products
UTMD

Overview Fund Activity

79 hedge funds and large institutions have $260M invested in Utah Medical Products in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+7
Holders Change %
+9.72%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
23
Reduced
31
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$34.3M
2
QC
2
Quadrature Capital
United Kingdom
$652K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$360K
4
GC
4
Globeflex Capital
California
$971K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$290K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$46.8M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$19M
3
BIP
3
Brandes Investment Partners
California
$0
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$1.96M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$22.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
76
Parallel Advisors
California
$8K +$8K +83 New
S
77
SignatureFD
Georgia
$1K +$1K +11 New
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$206 -$44 -442 -18%
BIP
79
Brandes Investment Partners
California
– -$857K -9,226 Closed
SG Americas Securities
80
SG Americas Securities
New York
– -$189K -2,039 Closed
EBA
81
Eagle Bay Advisors
New York
– -$2K -21 Closed
1 2 3
4